Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2019

18.01.2019 | Original article

Identification of new urinary risk markers for urinary stones using a logistic model and multinomial logit model

verfasst von: Atsushi Okada, Ryosuke Ando, Kazumi Taguchi, Shuzo Hamamoto, Rei Unno, Teruaki Sugino, Yutaro Tanaka, Kentaro Mizuno, Keiichi Tozawa, Kenjiro Kohri, Takahiro Yasui

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Risk assessment for urinary stones has been mainly based on urinary biochemistry. We attempted to identify the risk factors for urinary stones by statistically analyzing urinary biochemical and inflammation-related factors.

Methods

Male participants (age, 20–79 years) who visited Nagoya City University Hospital were divided into three groups: a control group (n = 48) with no history of stones and two stone groups with calcium oxalate stone experience (first-time group, n = 22; recurring group, n = 40). Using 25-µL spot urine samples, we determined the concentrations of 18 candidate urinary proteins, using multiplex analysis on a MagPix® system.

Results

In univariate logistic regression models classifying the control and first-time groups, interleukin (IL)-1a and IL-4 were independent factors, with significantly high areas under the receiver operating characteristic curve (1.00 and 0.87, respectively, P < 0.01 for both). The multivariate models with IL-4 and granulocyte–macrophage colony-stimulating factor (GM-CSF) showed higher areas under the receiver operating characteristic curve (0.93) compared to that for the univariate model with IL-4. In the classification of control, first-time, and recurrence groups, accuracy was the highest for the multinomial logit model with IL-4, GM-CSF, IL-1b, IL-10, and urinary magnesium (concordance rate 82.6%).

Conclusions

IL-4, IL-1a, GM-CSF, IL-1b, and IL-10 were identified as urinary inflammation-related factors that could accurately distinguish control individuals from patients with urinary stones. Thus, the combined analysis of urinary biochemical data could provide an index that more clearly evaluates the risk of urinary stone formation.
Literatur
1.
Zurück zum Zitat Scales CD Jr., Smith AC, Hanley JM, Saigal CS. Urologic diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRefPubMedPubMedCentral Scales CD Jr., Smith AC, Hanley JM, Saigal CS. Urologic diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71:209–13.CrossRefPubMed Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71:209–13.CrossRefPubMed
3.
Zurück zum Zitat Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120:109–16.CrossRefPubMed Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120:109–16.CrossRefPubMed
4.
Zurück zum Zitat Okada A, Nomura S, Higashibata Y, Hirose M, Gao B, Yoshimura M, et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res. 2007;35:89–99.CrossRefPubMed Okada A, Nomura S, Higashibata Y, Hirose M, Gao B, Yoshimura M, et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res. 2007;35:89–99.CrossRefPubMed
5.
Zurück zum Zitat Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, Itoh Y, et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res. 2009;24:908–24.CrossRefPubMed Okada A, Yasui T, Hamamoto S, Hirose M, Kubota Y, Itoh Y, et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res. 2009;24:908–24.CrossRefPubMed
6.
Zurück zum Zitat Okada A, Yasui T, Fujii Y, Niimi K, Hamamoto S, Hirose M, et al. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: detection by association analysis of stone-related gene expression and microstructural observation. J Bone Miner Res. 2010;25:2701–11.CrossRefPubMed Okada A, Yasui T, Fujii Y, Niimi K, Hamamoto S, Hirose M, et al. Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: detection by association analysis of stone-related gene expression and microstructural observation. J Bone Miner Res. 2010;25:2701–11.CrossRefPubMed
7.
Zurück zum Zitat Ichikawa J, Okada A, Taguchi K, Fujii Y, Zuo L, Niimi K, et al. Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome. Urolithiasis. 2014;42:17–28.CrossRefPubMed Ichikawa J, Okada A, Taguchi K, Fujii Y, Zuo L, Niimi K, et al. Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome. Urolithiasis. 2014;42:17–28.CrossRefPubMed
8.
Zurück zum Zitat Zuo L, Tozawa K, Okada A, Yasui T, Taguchi K, Ito Y, et al. A paracrine mechanism involving renal tubular cells, adipocytes and macrophages promotes kidney stone formation in a simulated metabolic syndrome environment. J Urol. 2014;191:1906–12.CrossRefPubMed Zuo L, Tozawa K, Okada A, Yasui T, Taguchi K, Ito Y, et al. A paracrine mechanism involving renal tubular cells, adipocytes and macrophages promotes kidney stone formation in a simulated metabolic syndrome environment. J Urol. 2014;191:1906–12.CrossRefPubMed
9.
Zurück zum Zitat Cao Q, Wang Y, Wang XM, Lu J, Lee VW, Ye Q, et al. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy. J Am Soc Nephrol. 2015;26:349–63.CrossRefPubMed Cao Q, Wang Y, Wang XM, Lu J, Lee VW, Ye Q, et al. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy. J Am Soc Nephrol. 2015;26:349–63.CrossRefPubMed
10.
11.
Zurück zum Zitat Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22:317–26.CrossRefPubMedPubMedCentral Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22:317–26.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cao Q, Wang C, Zheng D, Wang Y, Lee VW, Wang YM, et al. IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. J Am Soc Nephrol. 2011;22:1229–39.CrossRefPubMedPubMedCentral Cao Q, Wang C, Zheng D, Wang Y, Lee VW, Wang YM, et al. IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease. J Am Soc Nephrol. 2011;22:1229–39.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl 2011. 2014;4:34–8.PubMed Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl 2011. 2014;4:34–8.PubMed
14.
Zurück zum Zitat Taguchi K, Okada A, Kitamura H, Yasui T, Naiki T, Hamamoto S, et al. Colony-stimulating factor-1 signaling suppresses renal crystal formation. J Am Soc Nephrol. 2014;25:1680–97.CrossRefPubMedPubMedCentral Taguchi K, Okada A, Kitamura H, Yasui T, Naiki T, Hamamoto S, et al. Colony-stimulating factor-1 signaling suppresses renal crystal formation. J Am Soc Nephrol. 2014;25:1680–97.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Taguchi K, Okada A, Hamamoto S, Iwatsuki S, Naiki T, Ando R, et al. Proinflammatory and metabolic changes facilitate renal crystal deposition in an obese mouse model of metabolic syndrome. J Urol. 2015;194:1787–96.CrossRefPubMed Taguchi K, Okada A, Hamamoto S, Iwatsuki S, Naiki T, Ando R, et al. Proinflammatory and metabolic changes facilitate renal crystal deposition in an obese mouse model of metabolic syndrome. J Urol. 2015;194:1787–96.CrossRefPubMed
16.
Zurück zum Zitat Taguchi K, Okada A, Hamamoto S, Unno R, Moritoki Y, Ando R, et al. M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development. Sci Rep. 2016;6:35167.CrossRefPubMedPubMedCentral Taguchi K, Okada A, Hamamoto S, Unno R, Moritoki Y, Ando R, et al. M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development. Sci Rep. 2016;6:35167.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Okada A, Hamamoto S, Taguchi K, Unno R, Sugino T, et al. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. BMC Urol. 2018;18:19.CrossRefPubMedPubMedCentral Okada A, Hamamoto S, Taguchi K, Unno R, Sugino T, et al. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. BMC Urol. 2018;18:19.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Taguchi K, Hamamoto S, Okada A, Unno R, Kamisawa H, Naiki T, et al. Genome-wide gene expression profiling of Randall’s plaques in calcium oxalate stone formers. J Am Soc Nephrol. 2017;28:333–47.CrossRefPubMed Taguchi K, Hamamoto S, Okada A, Unno R, Kamisawa H, Naiki T, et al. Genome-wide gene expression profiling of Randall’s plaques in calcium oxalate stone formers. J Am Soc Nephrol. 2017;28:333–47.CrossRefPubMed
20.
Zurück zum Zitat Boswell RN, Yard BA, Schrama E, van Es LA, Daha MR, van der Woude FJ. Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines. Nephrol Dial Transplant. 1994;9:599–606.CrossRefPubMed Boswell RN, Yard BA, Schrama E, van Es LA, Daha MR, van der Woude FJ. Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines. Nephrol Dial Transplant. 1994;9:599–606.CrossRefPubMed
21.
Zurück zum Zitat Weisinger JR, Alonzo E, Bellorín-Font E, Blasini AM, Rodriguez MA, Paz-Martínez V, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996;49:244–50.CrossRefPubMed Weisinger JR, Alonzo E, Bellorín-Font E, Blasini AM, Rodriguez MA, Paz-Martínez V, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996;49:244–50.CrossRefPubMed
22.
Zurück zum Zitat Okumura N, Tsujihata M, Momohara C, Yoshioka I, Suto K, Nonomura N, et al. Diversity in protein profiles of individual calcium oxalate kidney stones. PLoS One. 2013;8:e68624.CrossRefPubMedPubMedCentral Okumura N, Tsujihata M, Momohara C, Yoshioka I, Suto K, Nonomura N, et al. Diversity in protein profiles of individual calcium oxalate kidney stones. PLoS One. 2013;8:e68624.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Yanagimachi MD, Niwa A, Tanaka T, Honda-Ozaki F, Nishimoto S, Murata Y, et al. Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. PLoS One. 2013;8:e59243.CrossRefPubMedPubMedCentral Yanagimachi MD, Niwa A, Tanaka T, Honda-Ozaki F, Nishimoto S, Murata Y, et al. Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. PLoS One. 2013;8:e59243.CrossRefPubMedPubMedCentral
Metadaten
Titel
Identification of new urinary risk markers for urinary stones using a logistic model and multinomial logit model
verfasst von
Atsushi Okada
Ryosuke Ando
Kazumi Taguchi
Shuzo Hamamoto
Rei Unno
Teruaki Sugino
Yutaro Tanaka
Kentaro Mizuno
Keiichi Tozawa
Kenjiro Kohri
Takahiro Yasui
Publikationsdatum
18.01.2019
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2019
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01693-x

Weitere Artikel der Ausgabe 5/2019

Clinical and Experimental Nephrology 5/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.